Note 4 - Stock Based Compensation
|
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Text Block] |
Note
4. Stock Based Compensation
The
Company recorded $326,651 of compensation expense related
to current and past option grants, restricted stock grants
and the Company’s Employee Stock Purchase Plan for
the nine month period ended June 30, 2012. The
Company recorded $208,557 of compensation expense related
to current and past equity awards for the nine month period
ended June 30, 2011. This expense is included in
selling, general and administrative
expense. There was no tax benefit from recording
this non-cash expense. As of June 30, 2012,
$869,306 of total unrecognized compensation expense related
to non-vested awards is expected to be recognized over a
weighted average period of approximately 3.2 years.
We
used the Black-Scholes option pricing model to determine
the weighted average fair value of options during the nine
months ended June 30, 2012 and June 30, 2011. The
weighted-average fair values at the grant date for options
issued during the nine months ended June 30, 2012 and 2011
were $4.12 and $3.29, respectively. This fair value was
estimated at grant date using the weighted-average
assumptions listed below.
The
expected stock price volatility is based on the historical
volatility of the Company’s stock for a period
approximating the expected life. The expected life
represents the period of time that options are expected to
be outstanding after their grant date. The risk-free
interest rate reflects the interest rate at grant date on
zero-coupon U.S. governmental bonds having a remaining life
similar to the expected option term.
During
the nine month period ended June 30, 2012, the Company
granted non-employee directors non-qualified stock options
to purchase an aggregate of 12,000 shares of common stock
with a contractual term of 6 years, a vesting term of one
year, an exercise price of $5.91 and a fair value of $4.12
per share. During the nine month period ended June 30,
2011, the Company granted key employees incentive stock
options and granted non-employee directors non-qualified
stock options to purchase an aggregate of 17,500 shares of
common stock with contractual terms of 6 years, vesting
terms between one and three years and a weighted average
exercise price of $4.67 with a fair value of $3.29 per
share.
During
the nine month period ended June 30, 2012, exercised stock
options totaled 168,148 shares, resulting in $147,707 of
proceeds to the Company. During the nine month period ended
June 30, 2011, exercised stock options totaled 74,251
shares, resulting in $58,944 of proceeds to the
Company.
Employee
Stock Purchase Plan
Clearfield,
Inc.’s Employee Stock Purchase Plan (ESPP) allows
participating employees to purchase shares of the
Company’s common stock at a discount through payroll
deductions. The ESPP is available to all employees subject
to certain eligibility requirements. Terms of the ESPP
provide that participating employees may purchase the
Company’s common stock on a voluntary after-tax
basis. Employees may purchase the Company’s common
stock at a price that is no less than the lower of 85% of
the fair market value of one share of common stock at the
beginning or end of each stock purchase period or phase.
The ESPP is carried out in six month phases, with phases
beginning on January 1 and July 1 of each calendar year.
For the phases that ended on June 30, 2012 and December 31,
2011, employees purchased 17,662 and 11,267 shares at a
price of $4.09 and $6.24 per share, respectively. After the
employee purchase on June 30, 2012, 238,842 shares of
common stock were available for future purchase under the
ESPP.
|